Prime

Oral Covid treatment yields promising trial data, drug makers say

German pharmaceutical giant Merck and a US partner reported promising results in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients' viral load. PHOTO | TOM MIHALEK | AFP

By  AFP

San Francisco

German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients' viral load. 

Related

Be the First to Know

Get the stories shaping East Africa — delivered straight to your inbox

Conflict

  1. Explainer: Why new war in Ethiopia’s Tigray threatens to trigger wider conflict

  2. Ethiopia, Sudan junta bicker again over RSF support claims

  3. East Africa’s oil rivalry is missing the bigger energy security question

  4. PRIME Why US proposal to expand Sudan arms embargo is stirring debate

Latest

  1. PRIME Scramble on for $62bn rare earths, niobium in Kenya’s Mrima Hill

  2. Explainer: Why new war in Ethiopia’s Tigray threatens to trigger wider conflict

  3. PRIME Dar port maintains lead against peers in efficiency

  4. PRIME Cereal disruption: Why wheat imports from Russia, Ukraine just got more costly

In the headlines

View All